Lung Transplant Patients D R clinical trials

Explore recruiting lung transplant patients d r clinical trials.

Also recruiting in Europe

Lung Transplant Patients D R trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective study to evaluate the efficacy of letermovir prophylaxis for the prevention of CMV infection in lung transplant recipients compared to a retrospective cohort treated with standard valganciclovir prophylaxis for 12 months (LETERCOR Study)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Lung Transplant Patients D R trials by city

Lung Transplant Patients D R in Toronto Lung Transplant Patients D R in Vancouver Lung Transplant Patients D R in Montreal Lung Transplant Patients D R in Calgary Lung Transplant Patients D R in Edmonton Lung Transplant Patients D R in Ottawa Lung Transplant Patients D R in Winnipeg Lung Transplant Patients D R in Quebec City Lung Transplant Patients D R in Hamilton Lung Transplant Patients D R in Kitchener Lung Transplant Patients D R in London Lung Transplant Patients D R in Halifax Lung Transplant Patients D R in New York Lung Transplant Patients D R in Los Angeles Lung Transplant Patients D R in Chicago Lung Transplant Patients D R in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease